Compare PRPO & IINN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PRPO | IINN |
|---|---|---|
| Founded | N/A | 2018 |
| Country | United States | Israel |
| Employees | N/A | N/A |
| Industry | Biotechnology: Laboratory Analytical Instruments | Medical/Dental Instruments |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 32.4M | 35.3M |
| IPO Year | N/A | 2021 |
| Metric | PRPO | IINN |
|---|---|---|
| Price | $24.75 | $0.85 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $2.00 |
| AVG Volume (30 Days) | 8.3K | ★ 203.3K |
| Earning Date | 11-14-2025 | 03-09-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $22,800,000.00 | $289,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $9,715.95 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 30.95 | N/A |
| 52 Week Low | $3.90 | $0.40 |
| 52 Week High | $28.50 | $1.65 |
| Indicator | PRPO | IINN |
|---|---|---|
| Relative Strength Index (RSI) | 53.51 | 36.71 |
| Support Level | $23.06 | $0.75 |
| Resistance Level | $24.92 | $0.97 |
| Average True Range (ATR) | 1.53 | 0.08 |
| MACD | 0.02 | -0.01 |
| Stochastic Oscillator | 31.14 | 20.98 |
Precipio Inc is a healthcare solutions company focused on cancer diagnostics. It focuses on addressing the problem of cancer misdiagnoses by developing solutions to mitigate the root causes of this problem in the form of diagnostic products, reagents, and services. The company operates Clinical Laboratory Improvement Amendments laboratories in both the New Haven, Connecticut and Omaha, Nebraska locations providing essential blood cancer diagnostics to office-based oncologists in many states nationwide. It provides new technologies to the oncology diagnostic laboratory market in the form of HemeScreen and IV-Cell product offerings. The company generates the majority of its revenue from third-party payers.
Inspira Technologies Oxy BHN Ltd is a specialty medical device company engaged in the research, development, manufacture, and marketing of proprietary respiratory support technology that is intended to provide an alternative to invasive mechanical ventilation (MV), which is the standard of care today for the treatment of respiratory failure. The respiratory care devices market is segmented geographically into North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.